Prosight Management’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.4M | Buy |
3,181,184
+1,102,869
| +53% | +$6.36M | 4.48% | 9 |
|
|
2025
Q1 | $13.7M | Buy |
2,078,315
+753,315
| +57% | +$4.97M | 4.51% | 7 |
|
|
2024
Q4 | $11.5M | Buy |
1,325,000
+619,891
| +88% | +$5.4M | 3.19% | 14 |
|
|
2024
Q3 | $13.8M | Buy |
705,109
+75,209
| +12% | +$1.47M | 3.39% | 11 |
|
|
2024
Q2 | $13M | Sell |
629,900
-330,100
| -34% | -$6.8M | 3.88% | 8 |
|
|
2024
Q1 | $20.5M | Buy |
960,000
+10,000
| +1% | +$213K | 5.7% | 5 |
|
|
2023
Q4 | $13.7M | Sell |
950,000
-982,456
| -51% | -$14.1M | 5.48% | 6 |
|
|
2023
Q3 | $17.6M | Buy |
1,932,456
+589,097
| +44% | +$5.37M | 5.59% | 5 |
|
|
2023
Q2 | $14.2M | Buy |
+1,343,359
| New | +$14.2M | 4.16% | 10 |
|
|
2020
Q4 | – | Sell |
-107,367
| Closed | -$3.29M | – | 44 |
|
|
2020
Q3 | $3.29M | Sell |
107,367
-577,633
| -84% | -$17.7M | 1.56% | 24 |
|
|
2020
Q2 | $11.2M | Sell |
685,000
-765,000
| -53% | -$12.5M | 4.79% | 3 |
|
|
2020
Q1 | $14.4M | Buy |
1,450,000
+414,000
| +40% | +$4.12M | 6.74% | 3 |
|
|
2019
Q4 | $14.2M | Buy |
1,036,000
+147,848
| +17% | +$2.03M | 6.25% | 4 |
|
|
2019
Q3 | $13.5M | Buy |
888,152
+20,342
| +2% | +$309K | 7.47% | 3 |
|
|
2019
Q2 | $17.1M | Buy |
867,810
+694,916
| +402% | +$13.7M | 8.62% | 3 |
|
|
2019
Q1 | $2.87M | Sell |
172,894
-143,687
| -45% | -$2.38M | 1.25% | 27 |
|
|
2018
Q4 | $4.45M | Buy |
316,581
+62,950
| +25% | +$884K | 2.29% | 18 |
|
|
2018
Q3 | $4.44M | Sell |
253,631
-34,256
| -12% | -$600K | 2.48% | 18 |
|
|
2018
Q2 | $5.24M | Buy |
+287,887
| New | +$5.24M | 3.84% | 14 |
|